Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Kah-Whye Peng, PhD, Linh Pham, Lianwen Zhang, PhD, Rebecca Nace, Nathan Jenks, Michael Steele, Alysha Newsom, Ronald Marler, DVM, PhD, Martha Q Lacy, MD, Stephen J. Russell, MD PhD

Blood (2017) 130 (Supplement 1): 1807.

https://doi.org/10.1182/blood.V130.Suppl_1.1807.1807

Published: 2017

Journal Articles

Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas

John M. Timmerman, MD, Kristopher K Steward, PhD, Reiko E Yamada, Patricia A Young, MD, Dena M. Minning, MD PhD, Raj K Sachdev, PhD, Michael J Gresser, PhD, Sanjay D Khare, PhD, Sherie L Morrison, PhD

Blood (2015) 126 (23): 2762.

https://doi.org/10.1182/blood.V126.23.2762.2762

Published: 2015

Journal Articles

Thrombopoietin Activates STAT2 Inducing Type I Interferon Effects and Gene Expression: Implications for in Vivo Tpo Treatment and for Myeloproliferative Neoplasms

Stefan N Constantinescu, MD PhD Prof., Jean-Philippe Defour, BPharm,, Celine Mouton, Isabelle Plo, William Vainchenker, MD PhD, Jean-Luc Villeval, PhD, Thomas Michiels, MD PhD, Judith Staerk, Christian Pecquet, PhD

Blood (2014) 124 (21): 820.

https://doi.org/10.1182/blood.V124.21.820.820

Published: 2014

Journal Articles

JAK1 and JAK2 Modulate Tumor Cell Susceptibility To Natural Killer (NK) Cells Through Regulation Of PDL1 Expression

Roberto Bellucci, PhD, Allison Martin, BS, Davide Bommarito, Kathy S. Wang, PhD, Gordon J Freeman, PhD, Jerome Ritz, MD

Blood (2013) 122 (21): 3472.

https://doi.org/10.1182/blood.V122.21.3472.3472

Published: 2013

Journal Articles

Interferon α Has Varied Effects On CD34 + Cells From Patients With Polycythemia Vera

Min Lu, PhD, Seungyeul Yoo, Lijuan Xia, Xiaoli Wang, Yan Li, Jun Zhu, Ronald Hoffman, MD

Blood (2013) 122 (21): 2840.

https://doi.org/10.1182/blood.V122.21.2840.2840

Published: 2013

Journal Articles

The Interferon Score Towards Interferon Alpha Tailored Therapy In Essential Thrombocythemia

Novella Pugliese, MD, Novella Pugliese, MD, Concetta Quintarelli, PhD, Biagio De Angelis, PhD, Luana Marano, Santa Errichiello, PhD, Nicola Esposito, Maddalena Raia, Claudio Cerchione, Luigi Del Vecchio, MD, Marco Picardi, MD, Vincenzo Martinelli, MD, Fabrizio Pane

Blood (2013) 122 (21): 4073.

https://doi.org/10.1182/blood.V122.21.4073.4073

Published: 2013

Journal Articles

Depletion of Jak2V617F MPN Stem Cells by IFNα in a Murine Model of Polycythemia Vera

Ann Mullally, MD, Claudia Bruedigam, Dirk Heckl, Luke Poveromo, Florian H. Heidel, MD, Geoff Hill, MD, Benjamin L. Ebert, MD, PhD, Steven W. Lane, MD PhD

Blood (2012) 120 (21): 806.

https://doi.org/10.1182/blood.V120.21.806.806

Published: 2012

Journal Articles

Anti-CD138-IFNα Fusion Proteins Are Effective in Treating Multiple Myeloma

Esther Yoo, PhD, Alex Vasuthasawat, Danh Tran, Alan Lichtenstein, MD, Sherie Morrison, PhD

Blood (2012) 120 (21): 939.

https://doi.org/10.1182/blood.V120.21.939.939

Published: 2012

Journal Articles

Direct Upregulation of Iron Regulatory Hormone Hepcidin by Interferon Alpha

Kazuhiko Ichiki, MD, Katsuya Ikuta, MD, PhD, Hiroki Tanaka, PhD, Yusuke Sasaki, Yasushi Shimonaka, Katsunori Sasaki, PhD, Satoshi Ito, MD, Motohiro Shindo, MD, PhD, Takaaki Ohtake, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD

Blood (2011) 118 (21): 2103.

https://doi.org/10.1182/blood.V118.21.2103.2103

Published: 2011

Journal Articles

Vascular endothelial growth factor–induced elimination of the type 1 interferon receptor is required for efficient angiogenesis

Hui Zheng, Juan Qian, Christopher J. Carbone, N. Adrian Leu, Darren P. Baker, Serge Y. Fuchs

Blood (2011) 118 (14): 4003–4006.

https://doi.org/10.1182/blood-2011-06-359745

Published: 2011

Journal Articles

ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon

Tekla Hornakova, Sabina Chiaretti, Muriel M. Lemaire, Robin Foà, Raouf Ben Abdelali, Vahid Asnafi, Marco Tartaglia, Jean-Christophe Renauld, Laurent Knoops

Blood (2010) 115 (16): 3287–3295.

https://doi.org/10.1182/blood-2009-09-245498

Published: 2010

Journal Articles

ALL-Associated JAK1 Mutations Confer Hypersensitivity to the Anti-Proliferative Effect of Type I Interferon.

Tekla Hornakova, Sabina Chiaretti, Muriel Lemaire, Robin Foà, Marco Tartaglia, Jean-Christophe Renauld, Laurent Knoops

Blood (2009) 114 (22): 3066.

https://doi.org/10.1182/blood.V114.22.3066.3066

Published: 2009

Journal Articles

Integrated Biochemical and Computational Approach Identifies BCL6 Direct Target Genes Controlling Multiple Pathways in Normal Germinal-Center B Cells

Masumichi Saito, PhD, Katia Basso, PhD, Pavel Sumazin, PhD, Adam A Margolin, PhD, Kai Wang, PhD, Wei-Keat Lim, Andrea Califano, PhD, Riccardo Dalla-Favera, MD

Blood (2008) 112 (11): 2434.

https://doi.org/10.1182/blood.V112.11.2434.2434

Published: 2008

Journal Articles

Prevention of Human Interferon-alpha-Induced Thrombocytopenia by a Non-Peptidyl Human Thrombopoietin Receptor Activator, NIP-004.

Akiko Yamane, Takanori Nakamura, Mamoru Ito, Yasuyuki Ohnishi, Yasuo Ikeda, Yoshitaka Miyakawa

Blood (2006) 108 (11): 1145.

https://doi.org/10.1182/blood.V108.11.1145.1145

Published: 2006

Journal Articles

Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica L. Haug, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, John A. Lust, MD, PhD, Leif Bergsagel, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 1555.

https://doi.org/10.1182/blood.V106.11.1555.1555

Published: 2005

Journal Articles

Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion.

John D. Dickinson, BA, Avadhut Joshi, BS, Jamie Gilmore, BS, Philip J. Bierman, MD, Sanger Warren, PhD, Shantaram S. Joshi, PhD

Blood (2004) 104 (11): 971.

https://doi.org/10.1182/blood.V104.11.971.971

Published: 2004

Journal Articles

Characterization of Interleukin-10 Receptor Expression on B-Cell Chronic Lymphocytic Leukemia Cells

Jesper Jurlander, Chun-Fai Lai, Jimmy Tan, Chuan-Chu Chou, Christian H. Geisler, Jeffrey Schriber, Leslie E. Blumenson, Satwant K. Narula, Heinz Baumann, Michael A. Caligiuri

Blood (1997) 89 (11): 4146–4152.

https://doi.org/10.1182/blood.V89.11.4146

Published: 1997

NARROW

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas

Thrombopoietin Activates STAT2 Inducing Type I Interferon Effects and Gene Expression: Implications for in Vivo Tpo Treatment and for Myeloproliferative Neoplasms

JAK1 and JAK2 Modulate Tumor Cell Susceptibility To Natural Killer (NK) Cells Through Regulation Of PDL1 Expression

Interferon α Has Varied Effects On CD34 + Cells From Patients With Polycythemia Vera

The Interferon Score Towards Interferon Alpha Tailored Therapy In Essential Thrombocythemia

Depletion of Jak2V617F MPN Stem Cells by IFNα in a Murine Model of Polycythemia Vera

Anti-CD138-IFNα Fusion Proteins Are Effective in Treating Multiple Myeloma

Direct Upregulation of Iron Regulatory Hormone Hepcidin by Interferon Alpha

Vascular endothelial growth factor–induced elimination of the type 1 interferon receptor is required for efficient angiogenesis

ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon

ALL-Associated JAK1 Mutations Confer Hypersensitivity to the Anti-Proliferative Effect of Type I Interferon.

Integrated Biochemical and Computational Approach Identifies BCL6 Direct Target Genes Controlling Multiple Pathways in Normal Germinal-Center B Cells

Prevention of Human Interferon-alpha-Induced Thrombocytopenia by a Non-Peptidyl Human Thrombopoietin Receptor Activator, NIP-004.

Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells.

Gene Expression in CLL Cells Associated with Lymphadenopathy and Chromosome 11q23 Deletion.

Characterization of Interleukin-10 Receptor Expression on B-Cell Chronic Lymphocytic Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only